Editor
A day after India’s drug regulator approved Covovax for restricted emergency use in children aged 7 to 11 years, the vaccine maker Serum Institute has written to the Centre seeking its inclusion in the national COVID-19 vaccination programme in the interest of public health, official sources said on Wednesday.
In a letter to the Union health ministry, Prakash Kumar Singh, Director, Government and Regulatory Affairs at Serum Institute of…
